Results 141 to 150 of about 214,511 (232)

Influence of Extended Itraconazole Antifungal Prophylaxis on the Development of Fungal Infections After Lung Transplant. [PDF]

J Transplant
Fischer S, Patel R, Mamawala M, Mathai SK, Vandervest K, Endicott-Yazdani T, Naik C, Grazia T, Fuller L.   +8 more
europepmc   +1 more source

DP042 | IMPACT OF ANTIFUNGAL PROPHYLAXIS ON TRANSPLANT-RELATED MORTALITY IN MISMATCHED ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT): A PROSPECTIVE EXPERIENCE FROM A SINGLE TRANSPLANT PROGRAM

Haematologica
Background In the allogeneic HSCT, the incidence of Invasive Fungal Disease is 7-9% with high rate of mortality. Although the antifungal prophylaxis is crucial, the role of anidulafungin is unknown.
A. Carobene, M. Pedata, M. Celentano, T. Ascione, C. Riccardi, S. Marotta, S. Leone, I. Migliaccio, C. Luise, U. De Martino, V. Oliva, S.M. Muggianu, M. Boccola, D. Buonanno, C. Falco, L. Altomare, A. Zuccarelli, M. Toriello, R. Penta, and A. Picardi   +19 more
doaj  

Incidence and outcomes of influenza-associated pulmonary aspergillosis and the role of antifungal prophylaxis: a structured literature review. [PDF]

Crit Care
Sedik S, Felber D, Schellongowski P, Salzer HJF, Bellmann R, Muhr T, Auer J, Krippl P, Lux M, Zajic P, Werner M, Bauer N, Watzinger N, Mesaric G, Tinawi Y, Dichtl K, Wolfgruber S, Biswas S, Prattes J, Feys S, van de Veerdonk FL, Heylen J, Wauters J, Carvalho A, Huguet M, Augusto V, Hoenigl M.   +26 more
europepmc   +1 more source

Comparing Efficacy and Safety of Itraconazole Solution Versus Posaconazole for Antifungal Prophylaxis After Heart Transplant. [PDF]

Open Forum Infect Dis
Tayyar R, Drucker D, Lee R, Le T, Teuteberg J, Khush K, Luikart H, Intrieri T, Moayedi Y, Alegria W, Dieringer T, Henricksen E, Subramanian A.   +12 more
europepmc   +1 more source

Epidemiology and Risk Factors for Invasive Fungal Infections in Pancreas Transplant in the Absence of Postoperative Antifungal Prophylaxis. [PDF]

Open Forum Infect Dis, 2023
Zachary J, Chen JM, Sharfuddin A, Yaqub M, Lutz A, Powelson J, Fridell JA, Barros N.   +7 more
europepmc   +1 more source

Choosing a Study Population for the Evaluation of Antifungal Prophylaxis [PDF]

Clinical Infectious Diseases, 2005
Oliver A, Cornely, Andrew J, Ullmann, Meinolf, Karthaus   +2 more
openaire   +2 more sources

Breakthrough Tracheobronchial Aspergillosis Caused by <i>Aspergillus calidoustus</i> and <i>Aspergillus niger</i> in a Lung Transplant Recipient Despite Combined Antifungal Prophylaxis. [PDF]

Case Rep Pulmonol
Calvache Benavides CE, Rodríguez Cárdenas MD, Sánchez Salazar SS, Treviño Rangel RJ, Camacho Ortiz A.   +4 more
europepmc   +1 more source

Efficacy and safety of antifungal prophylaxis in surgical intensive care unit patients: A systematic review and meta-analysis of randomized controlled trials. [PDF]

Biomed Rep
Kadariswantiningsih IN, Empitu MA, Danardono E, Rahmatullah I, Widya AM, Koendhori EB, Rampengan DDCH, Arima E, Endraswari PD.   +8 more
europepmc   +1 more source

Characterisation of Antifungal Prophylaxis and Therapy Among Inpatients With Haematological Malignancies in Non-Research Clinical Setting: A Multicentre Italian Experience. [PDF]

Mycoses
Marianna C, Matteo B, Giordana M, Francesca F, Luisa V, Francesco M, Claudia B, Ilaria DPM, Chiara TM, Chiara C, Marco P, Valentina B, Nicola F, Anna C, Katia P, Marta S, Simone C, Rosa F, Michela D, Fabio F, Stelvio B, Laura C, Annarosa C, Francesca C, Daniele Z, Daniele A, Grazia GM, Angelica S, Alessandro B, Livio P.   +29 more
europepmc   +1 more source

Fungal colonization and CLAD in lung transplant recipients: Implications for antifungal prophylaxis and graft survival. [PDF]

JHLT Open
Dhanani Z, Albaba I, Anjum F.
europepmc   +1 more source